Abstract
The risk of recurrence of PTLD in the subsequent transplant is influenced by time, details of the tumor, EBV viral load and serologic status, anti-viral therapy, but many questions remain unanswered.
Cite
CITATION STYLE
APA
Hanto, D. W. (2004, November). Retransplantation after post-transplant lymphoproliferative diseases (PTLD): When is it safe? American Journal of Transplantation. https://doi.org/10.1111/j.1600-6143.2004.00623.x
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free